Skip to content
Life Sciences Series A Founded 2017

Onchilles Pharma

Developer of small molecule therapeutics for cancer

📍 San Diego, United States · Oncology

Funding snapshot

Last roundSeries A
Amount$7M
Date10 June 2021

About

Developer of small molecule therapeutics for cancer. The company has discovered an anticancer protein neutrophil elastase ELANE released from neutrophils. It activates a pathway of the innate immune system with anti-cancer activity.

Latest news

No articles yet.

Raising like Onchilles Pharma?

Analyze your pitch deck before your next raise.

Analyze My Deck →